[1]
R. Giri, A. Naresh, J. S. Kushwaha, B. Kumar, R. K. Verma, and M. I. Khan, “Anti-albuminuric effects of spironolactone and its effect along with ramipril in type-2 diabetic nephropathy”, Int J Adv Med, vol. 6, no. 1, pp. 140–145, Jan. 2019.